Haplotypic and Genotypic Association of Catechol- O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
- PMID: 30018555
- PMCID: PMC6037851
- DOI: 10.3389/fphar.2018.00705
Haplotypic and Genotypic Association of Catechol- O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
Abstract
Treatment-resistant schizophrenia (TRS) continues to be a challenge. It was related to different factors, including alterations in the activity of brain dopaminergic system, which could be influenced by the dopamine-degrading enzyme, catechol-O-methyltransferase (COMT). Variants of the COMT gene have been extensively studied as risk factors for schizophrenia; however, their association with TRS has been poorly investigated. The aim of the present study was to determine the haplotypic and genotypic association of COMT rs4680 and rs4818 polymorphisms with the presence of TRS. Overall, 931 Caucasian patients diagnosed with schizophrenia (386 females and 545 males) were included, while 270 participants met the criteria for TRS. In males, no significant haplotypic and genotypic associations between COMT rs4680 and rs4818 polymorphisms and TRS were detected. However, genotypic analyses demonstrated higher frequency of COMT rs4680 AA genotype carriers compared to G-allele carriers (p = 0.033) and higher frequency of COMT rs4818 CC genotype carriers than G-allele carriers (p = 0.014) in females with TRS. Haplotype analyses confirmed that the presence of the G allele in females was associated with lower risk of TRS. In women with TRS, the high activity G-G/G-G haplotype was rare, while carriers of other haplotypes were overrepresented (p = 0.009). Such associations of COMT rs4680 and rs4818 high-activity (G variants), as well as G-G/G-G haplotype, with the lower risk of TRS in females, but not in males, suggest significant, but sex-specific influence of COMT variants on the development of treatment-resistance in patients with schizophrenia. However, due to relatively low number of females, those findings require replication in a larger sample.
Keywords: COMT rs4680 and rs4818 haplotype; COMT rs4680 polymorphism; COMT rs4818 polymorphism; sex-specific association; treatment-resistant schizophrenia.
Figures
Similar articles
-
Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia.Genes (Basel). 2023 Jun 27;14(7):1358. doi: 10.3390/genes14071358. Genes (Basel). 2023. PMID: 37510262 Free PMC article.
-
Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.Genes (Basel). 2023 Mar 10;14(3):689. doi: 10.3390/genes14030689. Genes (Basel). 2023. PMID: 36980961 Free PMC article. Review.
-
Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia.Sci Rep. 2020 Jun 22;10(1):10049. doi: 10.1038/s41598-020-67351-5. Sci Rep. 2020. PMID: 32572118 Free PMC article.
-
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884. Int Clin Psychopharmacol. 2010. PMID: 20531207
-
Are catechol-O-methyltransferase gene polymorphisms genetic markers for pain sensitivity after all? - A review and meta-analysis.Neurosci Biobehav Rev. 2023 May;148:105112. doi: 10.1016/j.neubiorev.2023.105112. Epub 2023 Feb 24. Neurosci Biobehav Rev. 2023. PMID: 36842714 Review.
Cited by
-
An In Vitro Study for the Role of Schizophrenia-Related Potential miRNAs in the Regulation of COMT Gene.Mol Neurobiol. 2024 Mar 1. doi: 10.1007/s12035-024-04070-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 38427212
-
Dental pain report in children and genetic polymorphism (rs4818) in Catechol-O-Methyltransferase (COMT) gene: a cross- sectional study.J Appl Oral Sci. 2024 Jan 5;32:e20230229. doi: 10.1590/1678-7757-2023-0229. eCollection 2024. J Appl Oral Sci. 2024. PMID: 38198369 Free PMC article.
-
Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia.Genes (Basel). 2023 Jun 27;14(7):1358. doi: 10.3390/genes14071358. Genes (Basel). 2023. PMID: 37510262 Free PMC article.
-
Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.Genes (Basel). 2023 Mar 10;14(3):689. doi: 10.3390/genes14030689. Genes (Basel). 2023. PMID: 36980961 Free PMC article. Review.
-
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives.Front Pharmacol. 2022 Oct 12;13:1005702. doi: 10.3389/fphar.2022.1005702. eCollection 2022. Front Pharmacol. 2022. PMID: 36313375 Free PMC article. Review.
References
-
- Akutagava-Martins G. C., Salatino-Oliveira A., Kieling C., Genro J. P., Polanczyk G. V., Anselmi L., et al. (2016). COMT and DAT1 genes are associated with hyperactivity and inattention traits in the 1993 Pelotas Birth Cohort: evidence of sex-specific combined effect. J. Psychiatry Neurosci. 41 405–412. 10.1503/jpn.150270 - DOI - PMC - PubMed
-
- American Psychiatric Association [APA] (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. Washington, DC: American Psychiatric Press.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
